[
  {
    "ts": null,
    "headline": "Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments",
    "summary": "Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory damages and $271.2 million dollars in punitive damages TARRYTOWN, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) applauds the jury verdict in the U.S. District Court for the District of Delaware that found that Amgen",
    "url": "https://finnhub.io/api/news?id=a35ff11d65b201e6b5e1543ff8ed78f4beb8db2b8979a8cbc5f5f382ad963ee5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747332120,
      "headline": "Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments",
      "id": 134483850,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory damages and $271.2 million dollars in punitive damages TARRYTOWN, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) applauds the jury verdict in the U.S. District Court for the District of Delaware that found that Amgen",
      "url": "https://finnhub.io/api/news?id=a35ff11d65b201e6b5e1543ff8ed78f4beb8db2b8979a8cbc5f5f382ad963ee5"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=b2c3863f21ea024039af577b54ef3a7ffa40a6d158c993ad88dfd05de4310729",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747327440,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 134493648,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=b2c3863f21ea024039af577b54ef3a7ffa40a6d158c993ad88dfd05de4310729"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
    "summary": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
    "url": "https://finnhub.io/api/news?id=fd1e66a44736b6d6f50983fe7f503a148cf2f8126ff69b21e676d5a2bc30f316",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747322280,
      "headline": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
      "id": 134489565,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
      "url": "https://finnhub.io/api/news?id=fd1e66a44736b6d6f50983fe7f503a148cf2f8126ff69b21e676d5a2bc30f316"
    }
  }
]